Hypoxic Exosomes Drive CCL26 in HNSCC - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Hypoxic Exosomes Drive CCL26 in HNSCC

Hypoxia-induced vesicles reshape endothelial signaling and may promote tumor-associated phenotypes in head and neck squamous cell carcinoma

  • By

  • Andrea Surnit

  • April 13, 2026

  • 3 min

Share

  • 1

    Hypoxia-induced exosomes from HNSCC cells enhance CCL26 secretion in endothelial cells, promoting tumor-associated phenotypes.

  • 2

    CCL26 neutralization or CCR3 silencing significantly reduced the tumor-promoting effects of hypoxic exosomes.

  • 3

    Increased CCL26 levels were confirmed in hypoxic conditions, correlating with enhanced cell viability, migration, and invasion.

  • 4

    Higher expression of CCL26 and hypoxia-inducible factor 1 alpha was observed in metastatic tumors compared to primary tumors.

  • 5

    The study highlights the need for in vivo validation of findings related to hypoxic exosomes and their effects on tumor biology.

Original Source(s)

Hypoxic Exosomes Drive CCL26 in HNSCC

  • by Andrea Surnit

  • April 13, 2026

Related Content

Most Miss Streamlined Neck Mass Dx Path

Same-visit biopsy and fewer empiric workup steps were linked to faster pathologic diagnosis in a retrospective analysis.

Misdiagnosis Common in Parkinsonian Disorders

Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.